Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Carver Biosciences Logo
Carver Biosciences Growth Score
52
CB Rank
347244
Heat Score
15
Carver Biosciences is a biotech company focused on the development of CRISPR/Cas13 antivirals.
Founded
obfuscation
PrivateSeed Boston, Massachusetts, United States1-10 www.carver.bio
Biotechnology
Overview

Carver Biosciences
Growth Score
52
Heat Score
15

Growth Score52
-5 pts
in past quarter
Heat Score 15
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Carver Biosciences

CB Rank
347244
Carver Biosciences is a biotech company focused on the development of CRISPR/Cas13 antivirals.
Founded
obfuscation
PrivateSeed Boston, Massachusetts, United States1-10 www.carver.bio
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name Carver Biosciences Inc.
Operating Status Active
Company Type For Profit
About the Company
Carver Biosciences is a biotech company focused on the development of CRISPR/Cas13 antivirals.
Predictions & Insights

Growth Insight

See this Growth Insight
Carver Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

CARVER Platform
A CRISPR/Cas13-based programmable antiviral platform designed to target and degrade RNA viruses by using guide RNA sequences for specificity.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed
obfuscation
Seed Round - Carver Biosciences Logo
Seed Round - Carver Biosciences
1
obfuscation
Khosla VenturesSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 4
News

News and Press

News•Mar 28, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

82
215.38%
 in past month

IT Spend

$238.3KThis year, Carver Biosciences is projected to spend $238.3K on IT, according to Aberdeen.

Active Website Tech Count

13Carver Biosciences is actively using 13 technologies for its website, according to BuiltWith. These include SSL by Default, LetsEncrypt, and  SPF.
Sub-Organizations
Frequently Asked Questions

Where is Carver Biosciences's headquarters? Carver Biosciences is located in Boston, Massachusetts, United States.Who invested in Carver Biosciences? Carver Biosciences is funded by Khosla Ventures.When was the last funding round for Carver Biosciences? Carver Biosciences closed its last funding round on
obfuscation
from a Seed round.Who are Carver Biosciences's competitors? Alternatives and possible competitors to Carver Biosciences may include Scribe Therapeutics, Metagenomi, and  Verve Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(397c9a6 1)
|